NetworkNewsBreaks

ThursdayJul 10, 2025 11:57 am

NetworkNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Named Finalist in UN WFP Innovation Program for AI-Powered Landmine Detection 

Safe Pro Group (NASDAQ: SPAI), an emerging leader in AI-powered security and threat detection, announced its subsidiary Safe Pro AI has been selected as a finalist in the United Nations World Food Programme’s Humanitarian Innovation Accelerator Innovation Weeks. Out of 579 global submissions, Safe Pro AI’s project—focused on using AI to detect landmines in Ukrainian agricultural fields—was one of eight chosen and the only U.S.-based AI solution selected. Finalists will compete for up to $150,000 in funding and a spot in a 12-month accelerator cohort. Safe Pro’s SPOTD platform leverages drone imagery and proprietary AI to identify over 150 types…

Continue Reading

ThursdayJul 10, 2025 11:36 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Raises $4.6 Million Through Warrant Exercise Agreement

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotech firm developing targeted therapies for genetic medicine delivery, announced a definitive agreement for the immediate cash exercise of outstanding warrants totaling 6,595,000 shares of common stock at a reduced price of $0.70 per share. The transaction is expected to generate approximately $4.6 million in gross proceeds. In exchange, the company will issue new unregistered warrants with the same share count, exercisable in six months at $0.70 and valid for five and a half years. Ladenburg Thalmann & Co. Inc. is serving as exclusive placement agent. Calidi plans to use the net proceeds…

Continue Reading

ThursdayJul 10, 2025 11:17 am

NetworkNewsBreaks – SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Positions for Growth Under Shifting U.S. and Canadian Clean Energy Policies 

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a North American solar and battery storage developer, announced strategic readiness to capitalize on clean energy incentives in both the U.S. and Canada. In response to the new “Big Beautiful Bill” federal legislation, which extends investment tax credits for projects started by July 4, 2026, SolarBank plans to accelerate construction on a 97 MW U.S. portfolio backed by $100 million in project financing from CIM Group. The company is advancing projects in key U.S. states with favorable permitting and interconnection progress to qualify under the new…

Continue Reading

ThursdayJul 10, 2025 9:30 am

NetworkNewsBreaks – ONAR Holding Corp. (OTCQB: ONAR) to Present on AI-Driven Commerce at GenAI Week Silicon Valley 2025

ONAR (OTCQB: ONAR), a marketing-technology company and agency network, announced that CEO Claude Zdanow will deliver a keynote at GenAI Week Silicon Valley 2025. His talk, “From SEO to LMO: How AI Language Models Are Rewriting the Rules of AI-Driven Digital Commerce,” is scheduled for July 14 from 12:00 to 12:20 p.m. PDT on the Align Stage. Zdanow will outline how Language Model Optimization (LMO) is replacing traditional SEO and share four key strategies for brands to succeed in the evolving AI-first commerce landscape. GenAI Week, taking place July 13–17 at the Santa Clara Convention Center, will host over 30,000…

Continue Reading

ThursdayJul 10, 2025 9:30 am

NetworkNewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Completes Historic REVIVE Trial, Sets Stage for Long COVID Breakthrough and Market Expansion 

Fifty 1 Labs (OTC: FITY), through its subsidiary Fifty1 AI Labs, LLC, announced the successful completion of the REVIVE Adaptive Platform Trial (NCT06128967), a groundbreaking Phase III study and the largest Long COVID trial to date. Conducted with global partners and top institutions including Stanford and Duke, the randomized, double-blind trial enrolled over 600 participants and demonstrated a clear treatment benefit using repurposed medicines. Powered by FITY’s proprietary AI platform, the trial sets a new standard in drug repurposing and personalized medicine, while supporting the company’s broader strategy to lead the $320.6 billion functional medicine market, pursue strategic acquisitions, and…

Continue Reading

ThursdayJul 10, 2025 9:10 am

NetworkNewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Completes Historic REVIVE Trial, Sets Stage for Long COVID Breakthrough and Market Expansion

Fifty 1 Labs (OTC: FITY), through its subsidiary Fifty1 AI Labs, LLC, announced the successful completion of the REVIVE Adaptive Platform Trial (NCT06128967), a groundbreaking Phase III study and the largest Long COVID trial to date. Conducted with global partners and top institutions including Stanford and Duke, the randomized, double-blind trial enrolled over 600 participants and demonstrated a clear treatment benefit using repurposed medicines. Powered by FITY’s proprietary AI platform, the trial sets a new standard in drug repurposing and personalized medicine, while supporting the company’s broader strategy to lead the $320.6 billion functional medicine market, pursue strategic acquisitions, and…

Continue Reading

ThursdayJul 10, 2025 9:00 am

NetworkNewsBreaks – Fusion Fuel Green PLC (Nasdaq: HTOO) Announces 1-for-35 Reverse Share Split to Regain Nasdaq Compliance

Fusion Fuel Green (Nasdaq: HTOO) today announced a 1-for-35 reverse share split of its Class A Ordinary Shares, effective at market open on Monday, July 14, 2025. The split is intended to restore compliance with Nasdaq’s minimum bid price requirement. Following the split, the number of outstanding Class A shares will decrease from approximately 27.4 million to 783,376, with the new CUSIP number G3R25D 209. No fractional shares will be issued, and any resulting fractions will be rounded up. Shareholders are not required to take action, as changes will be automatically reflected in accounts. The authorized share capital will remain…

Continue Reading

WednesdayJul 09, 2025 2:57 pm

NetworkNewsBreaks – Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Advances Portfolio in Walker Lane Hotspot

As Nevada’s Walker Lane becomes a prime target for mineral exploration, Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) is strategically positioned to capitalize, owning and developing four high-potential exploration properties in the area. “With a vision to evolve into Nevada’s premier silver and gold producer, Lahontan has built a robust portfolio of assets across this geologically diverse and historically rich trend,” reads a recent article. “The company controls four properties in the heart of Walker Lane: Santa Fe, West Santa Fe, Moho and Redlich. The company’s flagship project, the Santa Fe Mine, is a 26.4 km2 past-producing, oxide-hosted gold-silver property. Between 1988 and 1995,…

Continue Reading

WednesdayJul 09, 2025 1:25 pm

NetworkNewsBreaks – Adageis’ Platform Tackles Healthcare Complexities with AI

Adageis was featured in a recent article that discussed its powerful and patented AI-centric software solution. “Healthcare is a complicated place, and navigating the system is extremely difficult for patients,” Adageis’ CEO Shane Speirs was quoted as saying. “What Adageis does is provide a simple solution to healthcare organizations, ranging from large, multi-state, multi-specialty healthcare groups to independent practices across the country. We offer a solution that meets everyone’s needs, helping providers and organizations drive revenue by delivering high-quality care, which everyone can align with.” To view the full article, visit https://nnw.fm/OsbJv About Adageis Adageis is a healthcare technology innovator focused…

Continue Reading

WednesdayJul 09, 2025 11:32 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Lead Program in Virtual CEO Segment 

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company focused on treating primary and metastatic cancers in the brain and central nervous system, announced CEO John Climaco’s participation in a Virtual Investor CEO Connect segment. Climaco provided an overview of the Company’s lead candidate, TPI 287, and shared insights from the Longwood Healthcare Leaders Spring 2025 Meeting in Cambridge, Massachusetts. To view the full press release, visit https://nnw.fm/wo5J2 About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The…

Continue Reading